These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 25765020)

  • 21. Evaluation of a training program for device operators in the Australian Government's Point of Care Testing in General Practice Trial: issues and implications for rural and remote practices.
    Shephard MD; Mazzachi BC; Watkinson L; Shephard AK; Laurence C; Gialamas A; Bubner T
    Rural Remote Health; 2009; 9(3):1189. PubMed ID: 19689171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Point-of-care glucose and hemoglobin A1c in emergency department patients without known diabetes: implications for opportunistic screening.
    Ginde AA; Cagliero E; Nathan DM; Camargo CA
    Acad Emerg Med; 2008 Dec; 15(12):1241-7. PubMed ID: 18785943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Economic evaluation of Indigenous health worker management of poorly controlled type 2 diabetes in north Queensland.
    Segal L; Nguyen H; Schmidt B; Wenitong M; McDermott RA
    Med J Aust; 2016 Mar; 204(5):1961e-9. PubMed ID: 26985851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of Two Diabetes Point-of-care Analyzers Measuring Hemoglobin A1c in the Peruvian Amazon.
    Saxton AT; Miranda JJ; Ortiz EJ; Pan W
    Ann Glob Health; 2018 Nov; 84(4):618-624. PubMed ID: 30779508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Point-of-care testing improves diabetes management in a primary care clinic in South Africa.
    Motta LA; Shephard MDS; Brink J; Lawson S; Rheeder P
    Prim Care Diabetes; 2017 Jun; 11(3):248-253. PubMed ID: 28161128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of the Bayer DCA 2000+ for the measurement of glycated haemoglobin in a remote Australian Aboriginal community.
    Shemesh T; Piers LS; O'Dea K
    Ann Clin Biochem; 2003 Sep; 40(Pt 5):566-8. PubMed ID: 14503997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Point of care HbA
    Huangfu P; Laurence YV; Alisjahbana B; Ugarte-Gil C; Riza AL; Walzl G; Ruslami R; Moore DAJ; Ioana M; McAllister S; Ronacher K; Koesoemadinata RC; Grint D; Kerry S; Coronel J; Malherbe ST; Griffiths U; Dockrell HM; Hill PC; van Crevel R; Pearson F; Critchley JA
    Int J Tuberc Lung Dis; 2019 Mar; 23(3):283-292. PubMed ID: 30871659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HbA1c Is Associated with Frailty in a Group of Aboriginal Australians.
    Hyde Z; Smith K; Flicker L; Atkinson D; Fenner S; Skeaf L; Malay R; Lo Giudice D
    J Frailty Aging; 2019; 8(1):17-20. PubMed ID: 30734826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of point of care and laboratory HbA1c analysis: a MetroNet study.
    Schwartz KL; Monsur J; Hammad A; Bartoces MG; Neale AV
    J Am Board Fam Med; 2009; 22(4):461-3. PubMed ID: 19587262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sustaining better diabetes care in remote indigenous Australian communities.
    McDermott R; Tulip F; Schmidt B; Sinha A
    BMJ; 2003 Aug; 327(7412):428-30. PubMed ID: 12933731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using point-of-care HbA1c to facilitate the identification of diabetes and abnormal glucose regulation in primary healthcare settings.
    Pi L; Zheng Y; Shi X; Wang Z; Zhou Z
    Front Public Health; 2023; 11():1078361. PubMed ID: 37228727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycated hemoglobin assessment in clinical practice: comparison of the A1cNow point-of-care device with central laboratory testing (GOAL A1C Study).
    Kennedy L; Herman WH;
    Diabetes Technol Ther; 2005 Dec; 7(6):907-12. PubMed ID: 16386096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validity of random blood glucose as a predictor of the quality of glycaemic control by glycated haemoglobin in out-patient diabetic patients at Kenyatta National Hospital.
    Otieno FC; Ng'ang'a L; Kariuki M
    East Afr Med J; 2002 Sep; 79(9):491-5. PubMed ID: 12625691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accuracy and the Proper Use of the Point-of-Care Analysis in Hemoglobin A1C Measurement.
    Lynn L; Kay D; Younes N; Sen S; Jain V
    Metab Syndr Relat Disord; 2018 Apr; 16(3):117-121. PubMed ID: 29406816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of near-patient capillary glucose measurement and a risk assessment questionnaire in screening for type 2 diabetes in a high-risk population in rural India.
    Ritchie GE; Kengne AP; Joshi R; Chow C; Neal B; Patel A; Zoungas S
    Diabetes Care; 2011 Jan; 34(1):44-9. PubMed ID: 21193620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of glucometer and fasting blood glucose as screening tools for diabetes mellitus type 2 and glycated haemoglobin as clinical reference in rural community primary care settings of a middle income country.
    Muktabhant B; Sanchaisuriya P; Sarakarn P; Tawityanon W; Trakulwong M; Worawat S; Schelp FP
    BMC Public Health; 2012 May; 12():349. PubMed ID: 22583817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Results from 15years of quality surveillance for a National Indigenous Point-of-Care Testing Program for diabetes.
    Shephard M; Shephard A; McAteer B; Regnier T; Barancek K
    Clin Biochem; 2017 Dec; 50(18):1159-1163. PubMed ID: 28734906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1c on glycemic control in patients with type 2 diabetes: the Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial.
    Kennedy L; Herman WH; Strange P; Harris A;
    Diabetes Care; 2006 Jan; 29(1):1-8. PubMed ID: 16373887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utility of a point-of-care device in recruiting ethnic minorities for diabetes research with community partners.
    Nam S; Han HR; Song HJ; Song Y; Kim KB; Kim MT
    J Health Care Poor Underserved; 2011 Nov; 22(4):1253-63. PubMed ID: 22080707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for diabetes in Indigenous populations using glycated haemoglobin: sensitivity, specificity, post-test likelihood and risk of disease.
    Rowley KG; Daniel M; O'Dea K
    Diabet Med; 2005 Jul; 22(7):833-9. PubMed ID: 15975095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.